Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 14847 total
Peabody Energy heads into its October 29 earnings with the stock down 15% over the past month, shorts staying pat at a meaningful 9.3% of float, and options traders now hedging more aggressively than at any point this…
WTTR heads into the final days of September with an unusual split: the Street is getting more constructive just as short sellers accelerate their positioning, and the stock is sliding despite both. The short interest…
Inventiva has now reported, the stock barely moved on the day, and short sellers are not backing off. The borrow market described in last week's pre-results note has, if anything, tightened further since the September…
AnaptysBio enters the final days of Q3 with a crowded short book, a string of analyst target cuts, and a dense calendar of binary events starting in October. Short positioning has barely budged since the note published…
Howmet Aerospace enters the final session of September with two stories running in opposite directions: options traders just pushed defensive positioning to a fresh 52-week extreme, while the stock itself is trading…
Charter Communications has dropped 28% in a month to $110.67, short sellers have rebuilt positions over the week, and the options market is the most bullish it has been all year, creating one of the more contradictory…
Lamb Weston enters its October 6 earnings report with options traders pricing in more downside protection than at almost any point in the past year, while the stock sits 21% lower than a month ago. The options market…
FB Financial Corporation heads into its October 13 earnings with short positions building sharply, options traders nudging more defensive, and a stock that has shed 10% over the past month. The most striking…
Medpace Holdings heads into its October 19 earnings with a striking divergence at the top: the CEO is selling heavily in the open market while the Street's most recent analyst move is a bullish upgrade. The insider…
First Hawaiian heads into its October 23 earnings date with short sellers quietly trimming positions but options traders hedging more aggressively than at any point in recent months. The most striking divergence in the…
The most telling story at TRMD A this week is not the 2.5% price gain or the easing borrow market. It is the simultaneous, opposing moves by the company's two most senior executives. The CEO bought, the CFO sold, and…
SPCX ends September with the narrative shifting firmly toward the bulls: the short campaign that dominated the past two weeks is moderating, a cluster of new analyst initiations signals fresh institutional attention,…
RACE enters October with an unusual tension: the stock's lending market is among the most relaxed in its sector, yet its ORTEX short score has risen sharply over the past two weeks, and the family holding company that…
Willis Towers Watson heads into its October 29 earnings with a sharp one-month selloff, a Street that remains broadly bullish but is quietly pulling back targets, and borrow costs that have spiked fivefold in a week…
Wave Life Sciences ends the week with short sellers adding pressure to an already damaged stock, even as the institutional register shows a heavyweight activist holding firm. Short interest has climbed for the fourth…
HPE ended the week at $61.49, up 0.75% on the week but down 1.8% on Tuesday, with the story now shifting from pre-earnings positioning to what happens next after short sellers spent September in full retreat. The bear…
Surgery Partners heads into October with a curious split: short sellers are dug in at double-digit float levels, options traders are unusually bullish, and Wikipedia views just hit a near-record attention spike, all…
CC heads into its November earnings with short interest climbing, options hedging near a year-high, and the stock down 11% over the past month to $13.89, a setup that reflects deep unease rather than simple sector…
SYRE heads into the final quarter of 2026 with a stock down nearly 8% on the week, short interest growing steadily, and an ORTEX short score that has drifted higher every session this month. The clearest tension in the…
Medtronic has now fallen to $87.09, down a further 4.1% on the week, widening the gap between where the stock trades and where analysts think it belongs. The last note, published September 23, flagged the disconnect…
